To investigate the DNA methylation-specific sites of Mapk14 and validate the obtained results, we performed an in-depth analysis of the TCGA CRC patient data using the SurvivalMeth and MethSurv tools. The gene discussed is MAPK14; the disease is colorectal carcinoma.